Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helio S Sader

Showing results (41-50 of 420) with videos related to

Pageof 42
Sort By:
Diagnostic Microbiology and Infectious Disease|December 11, 2007
Tigecycline activity tested against 11808 bacterial pathogens recently collected from US medical centersAna C Gales, Helio S Sader, Thomas R Fritsche
Diagnostic Microbiology and Infectious Disease|January 22, 2011
Tigecycline activity tested against multidrug-resistant Enterobacteriaceae and Acinetobacter spp. isolated in US medical centers (2005-2009)Helio S Sader, David J Farrell, Ronald N Jones
The Journal of Antimicrobial Chemotherapy|February 27, 2004
Daptomycin activity and spectrum: a worldwide sample of 6737 clinical Gram-positive organismsJennifer M Streit, Ronald N Jones, Helio S Sader
Diagnostic Microbiology and Infectious Disease|May 10, 2005
Comparative activity of doripenem and three other carbapenems tested against Gram-negative bacilli with various beta-lactamase resistance mechanismsRonald N Jones, Helio S Sader, Thomas R Fritsche
Diagnostic Microbiology and Infectious Disease|August 18, 2005
Potency and spectrum trends for cefepime tested against 65746 clinical bacterial isolates collected in North American medical centers: results from the SENTRY Antimicrobial Surveillance Program (1998-2003)Helio S Sader, Thomas R Fritsche, Ronald N Jones
Diagnostic Microbiology and Infectious Disease|April 4, 2008
Antimicrobial activity of ceftobiprole, a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, tested against contemporary pathogens: results from the SENTRY Antimicrobial Surveillance Program (2005-2006)Thomas R Fritsche, Helio S Sader, Ronald N Jones
International Journal of Antimicrobial Agents|December 9, 2003
Contemporary in vitro spectrum of activity summary for antimicrobial agents tested against 18569 strains non-fermentative Gram-negative bacilli isolated in the SENTRY Antimicrobial Surveillance Program (1997-2001)Ronald N Jones, Helio S Sader, Mondell L Beach
Journal of Global Antimicrobial Resistance|November 23, 2016
In vitro activity of ceftaroline tested against isolates from the Asia-Pacific region and South Africa (2011)Robert K Flamm, Ronald N Jones, Helio S Sader
Diagnostic Microbiology and Infectious Disease|March 4, 2014
Ceftaroline activity against organisms isolated from respiratory tract infections in USA hospitals: results from the AWARE Program, 2009-2011Robert K Flamm, Helio S Sader, Ronald N Jones
Diagnostic Microbiology and Infectious Disease|March 27, 2007
Potency and spectrum of garenoxacin tested against an international collection of skin and soft tissue infection pathogens: report from the SENTRY antimicrobial surveillance program (1999-2004)Thomas R Fritsche, Helio S Sader, Ronald N Jones
Pageof 42

Showing results (41-50 of 420) with videos related to

Sort By:
Pageof 42
Diagnostic Microbiology and Infectious Disease|December 11, 2007
Tigecycline activity tested against 11808 bacterial pathogens recently collected from US medical centersAna C Gales, Helio S Sader, Thomas R Fritsche
Diagnostic Microbiology and Infectious Disease|January 22, 2011
Tigecycline activity tested against multidrug-resistant Enterobacteriaceae and Acinetobacter spp. isolated in US medical centers (2005-2009)Helio S Sader, David J Farrell, Ronald N Jones
The Journal of Antimicrobial Chemotherapy|February 27, 2004
Daptomycin activity and spectrum: a worldwide sample of 6737 clinical Gram-positive organismsJennifer M Streit, Ronald N Jones, Helio S Sader
Diagnostic Microbiology and Infectious Disease|May 10, 2005
Comparative activity of doripenem and three other carbapenems tested against Gram-negative bacilli with various beta-lactamase resistance mechanismsRonald N Jones, Helio S Sader, Thomas R Fritsche
Diagnostic Microbiology and Infectious Disease|August 18, 2005
Potency and spectrum trends for cefepime tested against 65746 clinical bacterial isolates collected in North American medical centers: results from the SENTRY Antimicrobial Surveillance Program (1998-2003)Helio S Sader, Thomas R Fritsche, Ronald N Jones
Diagnostic Microbiology and Infectious Disease|April 4, 2008
Antimicrobial activity of ceftobiprole, a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, tested against contemporary pathogens: results from the SENTRY Antimicrobial Surveillance Program (2005-2006)Thomas R Fritsche, Helio S Sader, Ronald N Jones
International Journal of Antimicrobial Agents|December 9, 2003
Contemporary in vitro spectrum of activity summary for antimicrobial agents tested against 18569 strains non-fermentative Gram-negative bacilli isolated in the SENTRY Antimicrobial Surveillance Program (1997-2001)Ronald N Jones, Helio S Sader, Mondell L Beach
Journal of Global Antimicrobial Resistance|November 23, 2016
In vitro activity of ceftaroline tested against isolates from the Asia-Pacific region and South Africa (2011)Robert K Flamm, Ronald N Jones, Helio S Sader
Diagnostic Microbiology and Infectious Disease|March 4, 2014
Ceftaroline activity against organisms isolated from respiratory tract infections in USA hospitals: results from the AWARE Program, 2009-2011Robert K Flamm, Helio S Sader, Ronald N Jones
Diagnostic Microbiology and Infectious Disease|March 27, 2007
Potency and spectrum of garenoxacin tested against an international collection of skin and soft tissue infection pathogens: report from the SENTRY antimicrobial surveillance program (1999-2004)Thomas R Fritsche, Helio S Sader, Ronald N Jones
Pageof 42